Solventum
$87.85Change from previous close: +0.09%Absolute change: +$0.08
At a glance
- Revenue growth
- +0.86%
- 2025 vs 2024
- Net income growth
- +224.84%
- 2025 vs 2024
- Net margin
- 18.7%
- 2024: 5.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | 227 | -189 | 95.0 | 76.0 | 169 | — |
| Depreciation and amortization | 133 | 135 | 117 | 121 | 122 | — |
| Capital expenditure | -83.0 | -84.0 | -63.0 | -97.0 | -110 | — |
| Investing cash flow | -87.0 | -77.0 | -745 | 3,766 | -110 | — |
| Financing cash flow | -300 | -50.0 | -115 | -2,693 | -110 | — |
| Share repurchases | -288 | -67.0 | — | — | 0.0 | 0.0 |
| Debt issued | 0.0 | 46.0 | 0.0 | 0.0 | 0.0 | — |
| Debt repaid | 0.0 | 0.0 | -100 | -2,770 | -100 | — |
| Effect of exchange rates | 3.0 | -2.0 | 1.0 | -1.0 | 6.0 | — |
| Net change in cash | -161 | -315 | -765 | 1,149 | -51.0 | — |
| Free cash flow | 144 | -273 | 32.0 | -21.0 | 59.0 | — |